United States · FDA National Drug Code directory
Evenity
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55513-880_1b60403e-86c5-4694-8cb5-2fc19f46dc49
- Product NDC
- 55513-880
- Form
- INJECTION, SOLUTION
- Composition / generic term
- romosozumab-aqqg
- Labeler
- Amgen, Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20190409
- Source listing expiry
- 20271231
Source-listed ingredients
- ROMOSOZUMAB — 105 mg/1.17mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE in 1 CARTON (55513-880-02) / 1.17 mL in 1 SYRINGE (55513-880-01) · 55513-880-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →